European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2020

The market is expected to reach $3.13 billion by 2019, at CAGR of 5.2% from 2014 to 2019.

The global vital signs monitoring market was valued at $3,148 million in the year 2012 and is poised to grow at a CAGR of 6.61% from the year 2013,

The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The global cell Analysis market is expected to reach USD 26.0 Billion by 2020 from USD 19.0 Billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020.

The health IT security market is expected to witness high growth in coming years. The market size, in terms of value, is expected to reach USD 9,867.5 Million by 2020 from USD 4,905.9 Million in 2015, at a CAGR of 15.0%.

Hematology Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019

The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020

This report studies the U.S. healthcare BPO market for payer, provider, and pharmaceutical outsourcing for the forecast period 2013 – 2018.

North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, mHealth, Telehealth, Healthcare analytics, Supply Chain Management, Revenue Cycle Management, CRM, Claims Management) by End User (Provider, Payer ) - Forecast to 2020

The market size, in terms of value, is expected to reach USD 9,867.5 Million by 2020 from USD 4,905.9 Million in 2015, at a CAGR of 15.0%.

The portable analytical instruments market is projected to reach USD 9.55 Billion by 2020 from USD 8.10 Billion in 2015, growing at a CAGR of 3.3% between 2015 and 2020.

The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period.

The Global Ophthalmology Devices Market is Projected to Reach USD 58.05 Billion by 2021, at a CAGR of 3.7% from 2016 to 2021.

The global infusion pumps and accessories market is expected to reach USD 10.2 Billion by 2020 at a CAGR of 5.8% during the forecast period.

Stem cell therapy is a kind of procedure used for treating or preventing a disease from spreading further into the body.

This report studies the global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

This report studies the European healthcare EDI market - Transaction Types and Its Penetration in 2015.

This report studies the European injectable drug delivery technologies market over the forecast period of 2015 to 2020.

The flow cytometry market is expected to reach USD 4.93 Billion by 2021 from USD 3.14 Billion in 2016, at a CAGR of 9.4% between 2016 and 2021.

North American Healthcare Cloud Computing Market by Application (PACS, RCM, EMR), by Deployment (Private, Public), by Service (SaaS, PaaS), & by End-User (Providers, Payers, Life Sciences) - Analysis & Forecasts to 2020

In this report, the HCIT outsourcing market is segmented on the basis of its application into provider outsourcing, payer outsourcing, life sciences outsourcing, operational services outsourcing, and infrastructure outsourcing.

The global aptamers market was valued at $200 million in the year 2012. At the end of 2015, the market is expected to be $287 million and is poised to reach approximately $2.1 billion by 2020, growing at a CAGR of 49.24% from 2015 to 2020.

The U.S. dominates the leukemia drug market in North America with 62% share; whereas Germany dominates the market of Europe with 31.05% share.

The global HTS market was valued at an estimated $13,735.88 million in 2013 and is poised to grow at a CAGR of 7.4% from 2013 to 2018, to reach $19,626.54 million by 2018.

This market is expected to reach USD 6.310 Billion by 2020 from USD 4.477 Billion in 2015, at a CAGR of 7.1%.

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.

This report studies the global particle size analysis market over the forecast period of 2016 to 2021. The market is expected to reach USD 256.1 Million by 2021, at CAGR of 4.7% from 2016 to 2021.

The health IT security market is expected to witness high growth in coming years. The market size, in terms of value, is expected to reach USD 9,867.5 Million by 2020 from USD 4,905.9 Million in 2015, at a CAGR of 15.0%.

The European Home Healthcare market has experienced extensive growth over the past few years, owing to rising aging population and technological advancements.

Vital Signs Monitoring Market - Market Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018

This report studies the global medical power supply market over the forecast period of 2012-2017.

This market is expected to reach USD 6.310 Billion by 2020 from USD 4.477 Billion in 2015, at a CAGR of 7.1%.

The leukemia therapeutics market was valued at $6.3 billion in 2010 and is expected to reach $11.3 billion by 2020 at a CAGR of 3.84% between 2015 and 2020.

The global digital x-ray market is expected to reach USD 10.46 Billion by 2020 from USD 6.15 Billion in 2015, at a CAGR of 11.2% from 2015 to 2020.

The Global Human Insulin Market Is Poised to reach ~USD 39.13 Billion by 2020, growing at a CAGR of 8.1% from 2015 to 2020 and studies the global human insulin market over the forecast period of 2015 to 2020.

This market is expected to reach USD 9.223 Billion by 2020 from USD 7.062 Billion in 2015, at a CAGR of 5.5%.

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.

The report provides a detailed overview of the major drivers, restraints, and opportunities impacting the global Nucleic acid Isolation and Purification market along with the estimates and forecasts of the revenue and market share analysis.

The portable analytical instruments market is projected to reach USD 9.55 Billion by 2020 from USD 8.10 Billion in 2015, growing at a CAGR of 3.3% between 2015 and 2020.

The global aptamers market was valued at $200 million in the year 2012. At the end of 2015, the market is expected to be $287 million and is poised to reach approximately $2.1 billion by 2020, growing at a CAGR of 49.24% from 2015 to 2020.

The U.S. IVD market is projected to reach USD 25.99 Billion in 2020 at a CAGR of 4.7% from 2015 to 2020.

This report studies the global genomics market for the forecast period of 2015 to 2020. This market is expected to reach USD 19.99 Billion by 2020 from USD 12.5 Billion in 2015, at a CAGR of 9.9%.

The market is estimated at USD 69.45 Billion in 2015 and is poised to grow at a CAGR of 6.2% during the forecast period, to reach USD 93.83 Billion by 2020.

The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period.

The global revenue cycle management market is anticipated to witness significant growth due to initiatives undertaken by governments for implementing RCM solutions, consolidation of healthcare providers, and decline in reimbursement rates

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.

This report studies the global patient portal market for the forecast period of 2015 to 2020. This market is expected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1%.

The global virus filtration market is projected to reach USD 3.25 Billion by 2020 from USD 1.82 Billion in 2015, at a CAGR of 12.3% between 2015 and 2020.

The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020.